Related Experiment Videos
Summary
High-dose frusemide in chronic renal failure did not improve intrinsic renal function, such as glomerular filtration rate (GFR). However, it significantly increased urine volume and sodium and potassium excretion in patients.
Area of Science:
- Nephrology
- Pharmacology
Background:
- Chronic renal failure (CRF) presents challenges in managing fluid and electrolyte balance.
- The effect of high-dose diuretics on renal function in CRF patients is not fully understood.
Purpose of the Study:
- To investigate whether high-dose frusemide administration improves glomerular filtration rate (GFR) in patients with stable chronic renal failure.
- To assess the impact of high-dose frusemide on renal function and electrolyte excretion in CRF.
Main Methods:
- A 20-day study involving 7 patients with stable chronic renal failure.
- 10 days of baseline observation followed by 10 days of oral high-dose frusemide (1 gram daily).
- Daily monitoring of fluid balance, urine output, and electrolyte levels (sodium, potassium, urea, creatinine).
Main Results:
- Significant increases in urine volume, sodium excretion, and potassium excretion were observed during frusemide treatment (p<0.01 for water and sodium, p<0.05 for potassium).
- No significant changes were found in blood pressure, weight, creatinine clearance, urea clearance, or serum electrolyte levels.
- Intrinsic renal function, as measured by creatinine clearance, remained unchanged.
Conclusions:
- High-dose frusemide (1 gram) does not enhance intrinsic renal function or glomerular filtration rate in patients with stable chronic renal failure.
- While not improving renal function, high-dose frusemide effectively increases urine output and sodium/potassium excretion in this patient population.